CYNATA THERAPEUTICS LIMITED

CYP

equity

AUD $0.32

0.010 (3.23%)

Updated: 20 Jan, 4:57 am UTC

Description

Cynata Therapeutics Limited (ASX: CYP) is an Australian therapeutics and regenerative medicine company developing a platform technology for the manufacturing of stem cell-derived products. Its primary objective is to develop and commercialise its Cymerus™ stem cell technology, which has the potential to revolutionise the development of cell therapies. The company is also developing a portfolio of stem cell and cytokine-based products for the treatment of serious diseases with unmet medical need.

Activity
Last price		$0.32
Change		0.010 (3.23%)
Bid/Ask		$0.30 - $0.32
Volume		22,627.00
Volume traded/total %		0.016%
Volume avg (4w)		48,718.00
Open		$0.32
Day range		$0.32 - $0.33
Previous Close		$0.31
Last Trade		20 Jan, 4:57 am UTC

Size
Market Cap		$44.42M
Market Rank		1467
Industry Rank		44

Fundamentals
Shares Issued		143.28M
Earnings Per Share (EPS)		$-0.038
Dividends Per Share (DPS)		-
P/E Ratio		-

Similar to